RNA-Seq Time-Course Analysis of NPCs Transcriptome in Response to HSV-1 Infection
RNA-seq (gene expression) · human · 53 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Homo sapiens (human)
- Samples
- 53 samples: 6 conditions, mostly with about 9 replicates eachGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- RNA-Seq time-course analysis of neural precursor cell transcriptome in response to herpes simplex Virus-1 infectionJournal of neurovirology · 2024
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE236646_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA991956 and SRA study SRP447866. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 53 samples.
How we read this: 6 replicated groups read from 53 sample titles; they account for 53 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM7566918 A1: infected at MOI 0.0001 + 5BVdU + IFN-alpha - Day 3 infected at MOI 0.0001 …
- GSM7566919 A2: infected at MOI 0.0001 + 5BVdU + IFN-alpha - Day 3 infected at MOI 0.0001 …
- GSM7566920 A3: infected at MOI 0.0001 + 5BVdU + IFN-alpha - Day 3 infected at MOI 0.0001 …
- GSM7566921 B1: infected at MOI 0.0001 - Day 3 infected at MOI 0.0001 …
- GSM7566922 B2: infected at MOI 0.0001 - Day 3 infected at MOI 0.0001 …
- GSM7566923 B3: infected at MOI 0.0001 - Day 3 infected at MOI 0.0001 …
- GSM7566924 C1: infected at MOI 0.001 + 5BVdU + IFN-alpha - Day 3 infected at MOI 0.001 +…
- GSM7566925 C2: infected at MOI 0.001 + 5BVdU + IFN-alpha - Day 3 infected at MOI 0.001 +…
- GSM7566926 C3: infected at MOI 0.001 + 5BVdU + IFN-alpha - Day 3 infected at MOI 0.001 +…
- GSM7566927 D1: infected at MOI 0.001 - Day 3 infected at MOI 0.001 -…
- GSM7566928 D2: infected at MOI 0.001 - Day 3 infected at MOI 0.001 -…
- GSM7566929 D3: infected at MOI 0.001 - Day 3 infected at MOI 0.001 -…
- GSM7566930 E1: Uninfected + 5BVdU + IFN-alpha – Day 3 Uninfected + 5BVdU + IF…
- GSM7566931 E2: Uninfected + 5BVdU + IFN-alpha – Day 3 Uninfected + 5BVdU + IF…
- GSM7566932 E3: Uninfected + 5BVdU + IFN-alpha – Day 3 Uninfected + 5BVdU + IF…
- GSM7566933 F1: Uninfected - Day 3 Uninfected - Day
- GSM7566934 F2: Uninfected - Day 3 Uninfected - Day
- GSM7566935 F3: Uninfected - Day 3 Uninfected - Day
- GSM7566936 G1: Uninfected - Day 5 Uninfected - Day
- GSM7566937 G2: Uninfected - Day 5 Uninfected - Day
- GSM7566938 G3: Uninfected - Day 5 Uninfected - Day
- GSM7566939 H1: Uninfected + 5BVdU + IFN-alpha – Day 5 Uninfected + 5BVdU + IF…
- GSM7566940 H2: Uninfected + 5BVdU + IFN-alpha – Day 5 Uninfected + 5BVdU + IF…
- GSM7566941 H3: Uninfected + 5BVdU + IFN-alpha – Day 5 Uninfected + 5BVdU + IF…
- GSM7566942 I1: infected at MOI 0.001 - Day 5 infected at MOI 0.001 -…
- GSM7566943 I2: infected at MOI 0.001 - Day 5 infected at MOI 0.001 -…
- GSM7566944 I3: infected at MOI 0.001 - Day 5 infected at MOI 0.001 -…
- GSM7566945 J1: infected at MOI 0.001 + 5BVdU + IFN-alpha - Day 5 infected at MOI 0.001 +…
- GSM7566946 J2: infected at MOI 0.001 + 5BVdU + IFN-alpha - Day 5 infected at MOI 0.001 +…
- GSM7566947 J3: infected at MOI 0.001 + 5BVdU + IFN-alpha - Day 5 infected at MOI 0.001 +…
- GSM7566948 K1: infected at MOI 0.0001 - Day 5 infected at MOI 0.0001 …
- GSM7566949 K2: infected at MOI 0.0001 - Day 5 infected at MOI 0.0001 …
- GSM7566950 K3: infected at MOI 0.0001 - Day 5 infected at MOI 0.0001 …
- GSM7566951 L1: infected at MOI 0.0001 + 5BVdU + IFN-alpha - Day 5 infected at MOI 0.0001 …
- GSM7566952 L2: infected at MOI 0.0001 + 5BVdU + IFN-alpha - Day 5 infected at MOI 0.0001 …
- GSM7566953 L3: infected at MOI 0.0001 + 5BVdU + IFN-alpha - Day 5 infected at MOI 0.0001 …
- GSM7566954 M1: Uninfected - Day 7 Uninfected - Day
- GSM7566955 M2: Uninfected - Day 7 Uninfected - Day
- GSM7566956 M3: Uninfected - Day 7 Uninfected - Day
- GSM7566957 N1: Uninfected + 5BVdU + IFN-alpha – Day 7 Uninfected + 5BVdU + IF…
+ 13 more — browse all 53 samples with per-sample file links →
- GSE309595 Longitudinal Analysis of Multiple Myeloma: Therapeutic Response and Immune Microenvironment Dynamics in the Context of Tumor Heterogeneity [scRNA-seq] 270 samples shares rna-seq
- GSE308103 Single-nucleus RNA-sequencing (snRNA-seq) analysis of normal lung tissues, precursor lung lesions and invasive lung adenocarcinomas 75 samples shares rna-seq
- GSE292858 RNA-Seq analysis of tumor and matched normal samples from colorectal cancer patients. 73 samples shares rna-seq
- GSE319641 RNA-Seq profiling of pre- and on-treatment tumor samples from breast cancer patients enrolled in the NeoTRIP trial. 401 samples shares rna-seq
- GSE205154 Bulk RNA-Seq gene expression data for 289 primary and metastatic pancreatic ductal adenocarcinoma (PDAC) tumor samples from FFPE blocks. 289 samples shares rna-seq
- GSE339456 Integrated bulk and spatial transcriptomic analysis identifies progression-associated molecular signatures in biopsy-proven hypertensive nephropathy [RNA-seq] 35 samples shares rna-seq
- GSE261713 Linking single cell genomes and transcriptomes at scale to decode breast cancer progression [scRNA-seq] 35 samples shares rna-seq
- GSE317068 Multiscale analysis and functional validation of the cellular and genetic determinants of skeletal disease [Human scRNA-seq] 32 samples shares rna-seq
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.